ARDX

Ardelyx, Inc.

Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$5.94

Market Cap

$1.46B

Beta

0.62

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+22.09%

EPS Growth (YoY)-55.14%

Revenue CAGR 3Y+98.40%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.02%

Debt / Equity1.27

Interest Coverage-1.4x

No credit card required

Already have an account? Sign in to view the full analysis for ARDX.